ليست عنوان مقالات لاتين Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Type 2 Diabetes Mellitus Correctable viual impairment in an older population: the blue mountain eye tudy

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Type 2 Diabetes Mellitus

2

Coronary Computed Tomographic Angiographic Findings in Patients With Kawasaki Disease

3

Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical Procedures: Results From the Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry

4

Coronary Computed Tomographic Angiography for Prediction of Procedural and Intermediate Outcome of Bypass Grafting to Left Anterior Descending Artery Occlusion With Failed Visualization on Conventional Angiography

5

Coronary Computed Tomography Angiography After Stress Testing

6

Coronary Computed Tomography Angiography After Stress Testing: Results From a Multicenter, Statewide Registry, ACIC (Advanced Cardiovascular Imaging Consortium)

7

Coronary Computed Tomography Angiography as a Screening Tool for the Detection of Occult Coronary Artery Disease in Asymptomatic Individuals Original Research Article

8

Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain: The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) Trial

9

Coronary computed tomography angiography in a patient with atrial fibrillation, case report

10

Coronary Computed Tomography Angiography in the Emergency Department: The High Stakes Game of Low Risk Chest Pain

11

Coronary Computed Tomography Angiography Versus Coronary Calcium Computed Tomography for Prognosis With Regard to Mortality

12

Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials

13

Coronary Computed Tomography Angiography: CONFIRMations and Perspectives

14

Coronary Computed Tomography Angiography: Is it Time to Replace the Conventional Coronary Angiogram in Heart Transplant Patients?

15

Coronary Computed Tomography Angiography: Our Time Has Come, But There Are Miles to Go Before We Sleep

16

Coronary Computed Tomography Angiography: The Challenge of Coronary Calcium

17

Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients

18

Coronary constriction in constrictive pericarditis

19

Coronary C-reactive protein distribution: its relation to development of atherosclerosis

20

Coronary CT Angiography Again Results in Better Patient Outcomes

21

Coronary CT Angiography and Dual-Energy Computed Tomography in Ischemic Heart Disease Suspected Patients

22

Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis

23

Coronary Diameter and Vasodilator Function in Children Following Arterial Switch Operation for Complete Transposition of the Great Arteries

24

Coronary Dilator Reserve and Morphological Changes After Relief of Pressure-overload in Rats

25

Coronary disease––prone behavior among Japanese men: Job-centered lifestyle and social dominance, ,

26

Coronary dissection and thrombosis after ingestion of ephedra

27

Coronary dominance and prognosis of patients with acute coronary syndrome

28

Coronary Doppler intensity changes during handgrip: new method to detect coronary vasomotor tone in coronary artery disease

29

Coronary drug-eluting stent development: Issues in trial design

30

Coronary echocardiography in tetralogy of Fallot: diagnostic accuracy, resource utilization and surgical implications over 13 years

31

Coronary Ectasia Is Associated with Impaired Left Ventricular Myocardial Performance in Patients without Significant Coronary Artery Stenosis

32

Coronary Emboli in a Young Patient with Mechanical Aortic Valve: A Rare Cause of Acute Myocardial Infarction

33

Coronary Embolism and Myocardial Infarction in a Transgender Male Undergoing Hormone Therapy: A Case Report and Review of the Literature

34

Coronary Embolism and Subsequent Myocardial Abscess Complicating Ventricular Aneurysm and Tachycardia

35

Coronary embolism causing myocardial infarction in a patient with mechanical aortic valve prosthesis

36

Coronary embolism complicating an atrial myxoma

37

Coronary embolism complicating aortic valve endocarditis: Treatment with successful coronary angioplasty

38

Coronary Embolization in Bullet Wounds: Role of Perioperative Coronary Angiography

39

Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCI

40

Coronary embolus secondary to a prosthetic mitral valve and subtherapeutic anticoagulation

41

Coronary endarterectomy and stent removal after iatrogenic perforation

42

Coronary Endarterectomy and Stent Removal in Patients With In-Stent restenosis

43

Coronary endarterectomy with off-pump coronary artery bypass surgery

44

Coronary Endarterectomy: Impact on Morbidity and Mortality When Combined With Coronary Artery Bypass Surgery

45

Coronary Endarterectomy: The Choice of Tactics is Dictated by the Lay of the Land

46

Coronary endothelial dysfunction after Kawasaki disease

47

Coronary Endothelial Dysfunction After Kawasaki Disease: Evaluation by Intracoronary Injection of Acetylcholine

48

Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans

49

Coronary endothelial dysfunction and inflammation of coronary atherosclerosis

50

Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy

51

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

52

Coronary endothelial dysfunction in the early months after heart transplantation

53

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

54

Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid

55

Coronary Endothelial Dysfunction Precedes Heart Failure and Reduction of Coronary Reserve in Awake Dogs

56

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

57

Coronary endothelial injury after local occlusion on the human beating heart

58

Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression Original Research Article

59

Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: Correlation of asynchronous hemodynamics and pathology in vivo

60

Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig

61

Coronary events and coronary care: MONICA project

62

Coronary events and coronary care: MONICA project

63

Coronary events and coronary care: MONICA project

64

Coronary events and coronary care: MONICA project

65

Coronary fistula between the left anterior descending coronary artery and the pulmonary artery: Two case reports

66

Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography

67

Coronary Flow Dynamics Measured by Computed Tomography Angiography

68

Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries

69

Coronary flow reserve and brachial artery reactivity in patients with chest pain and “false positive” exercise-induced ST-segment depression

70

Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension

71

Coronary Flow Reserve Assessed by Transesophageal Echocardiography Identifies Early Restenosis of the Left Anterior Descending Coronary Artery Angioplasty

72

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

73

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

74

Coronary flow reserve assessment from average peak velocity profiles alone must be judged with caution

75

Coronary Flow Reserve Before and After Coronary Artery Bypass Surgery

76

Coronary flow reserve does not adequately interrogate coronary microvascualr function

77

Coronary Flow Reserve During Coronary Angioplasty in Patients With Recent Myocardial Infarction: Relation to Stenosis and Myocardial Viability

78

Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function

79

Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study

80

Coronary flow reserve in composite arterial Y grafts

81

Coronary Flow Reserve in Hypertensive Patients With Hypercholesterolemia and Without Coronary Heart Disease

82

Coronary Flow Reserve in the Left Anterior Descending Artery Patients, Diagnostic and Prognostic Value of Doppler Echocardiogrphy

83

Coronary flow reserve is also impaired in patients with subclinical hypothyroidism

84

Coronary flow reserve is impaired in patients with aortic valve calcification

85

Coronary flow reserve is impaired in patients with slow coronary flow

86

Coronary Flow Reserve Is Impaired in Young Men With Familial Hypercholesterolemi

87

Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow, ,

88

Coronary flow reserve measurement in the coronary sinus in pre and post CABG status

89

Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease

90

Coronary flow reserve or brachial artery flow to assess endothelial dysfunction: is it time to look at the heart again?

91

Coronary Flow Reserve With a Turbo: A Warning for the Use of Adenosine as a Provocative Test in Patients Receiving Ticagrelor?

92

Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?

93

Coronary flow velocity changes after intravenous dipyridamole infusion: Measurements using intravascular Doppler guide wire documentation of flow inhomogeneity

94

Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction

95

Coronary flow velocity reserve and indices describing aortic distensibility in patients after coronary angiography

96

Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention Original Research Article

97

Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease : Results from the pilot phase of the Women’s Ischemi Syndrome Evaluation (WISE) Study

98

Coronary flow, VO2 peak and anaerobic threshold in patients with dilated cardiomyopathy

99

Coronary flow: how far can we go with echocardiography?

100

Coronary Flow: The Holy Grail of Echocardiography?

101

Coronary grafting using a temporary intraluminal shunt instead of heart-lung bypass

102

Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression

103

Coronary heart disease and associated risk factors in Qazvin: a population-based study

104

Coronary heart disease and chlamydia pneumoniae DNA in blood mononuclear cells

105

Coronary heart disease and lipid-modifying treatment in african american patients

106

Coronary heart disease and vitamin E

107

Coronary heart disease deaths and infarctions in people with little or no coronary calcium

108

Coronary heart disease in Chile

109

Coronary heart disease in Indian Asians

110

Coronary heart disease in Indian Asians

111

Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management Review Article

112

Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization Review Article

113

Coronary heart disease in people of south-Asian origin

114

Coronary heart disease in seven countries

115

Coronary heart disease in South Asia: Need to redefine risk

116

Coronary heart disease inequalities: deaths and the socio-economic environment in Nottingham, England

117

Coronary heart disease is a multifactorial disease

118

Coronary heart disease mortality among Arab and Jewish residents of Jerusalem

119

Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates Original Research Article

120

Coronary heart disease mortality and sudden death among the 35–44-year age group in Allegheny County, Pennsylvania

121

Coronary heart disease mortality for six ethnic groups in California, 1990–2000

122

Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study

123

Coronary heart disease risk factors and menopause: a study in 1684 French women Original Research Article

124

Coronary heart disease risk factors in urban bus drivers

125

Coronary heart disease risk-factor profile in a lower middles class urban community in Pakistan

126

Coronary heart disease still dropping in UK

127

CORONARY HEART DISEASE TOGETHER WITH DIABETES POSES A SERIOUS HEALTH THREAT

128

Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies, , ,

129

Coronary heart disease, shared care, and cholesterol

130

Coronary heart disease, stroke, and hypertension in a U.S. National cohort: The NHANES I Epidemiologic Follow-up Study

131

Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population

132

Coronary heart disease: Intervention for intimate relationship issues Original Research Article

133

Coronary Heart Disease: Pandemic in a True Sense

134

Coronary heart disease: where have we been and where are we going?

135

Coronary heart disease:: At the interface of molecular genetics and preventive medicine

136

Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon

137

Coronary hemodynamics in patients with symptomatic hypertrophic cardiomyopathy

138

Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty

139

Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up

140

Coronary in-stent restenosis following beta brachytherapy A histopathological examination

141

Coronary in-stent restenosis: Current status and future strategies

142

Coronary Insufficiency After Stentless Aortic Root Replacement: Risk Factors and Solutions

143

Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology

144

Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?

145

Coronary Intervention Without a Safety Net

146

Coronary Intervention, Restenosis and Complications

147

Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy

148

Coronary interventions: clinical outcomes and non-stent techniques

149

Coronary interventions: keeping score

150

Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis

151

Coronary involvement in Takayasuʹs arteritis

152

Coronary ischemia and percutaneous intervention

153

Coronary ischemia induced Wolf Parkinson White syndrome

154

Coronary ischemic disease, arterial stiffness, and pulse pressure

155

Coronary Ischemic Events after First Atrial Fibrillation: Risk and Survival

156

Coronary lesions at increased risk

157

Coronary lumen at six-month follow-up of a new radiopaque cordis tantalum stent using quantitative angiography and intracoronary ultrasound

158

Coronary Magnetic Resonance Imaging: Coming of Age

159

Coronary malperfusion due to type a aortic dissection: mechanism and surgical management

160

Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics

161

Coronary microcirculation: Physiology and mechanics

162

Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina

163

Coronary microembolization

164

Coronary microembolization

165

Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction

166

Coronary microvascular abnormalities in Chagasʹ disease

167

Coronary microvascular dilation is impaired during cold pressor test in diabetic patients with angiographically normal coronary arteries

168

Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure

169

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study

170

Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox

171

Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries

172

Coronary microvascular function and myocardial metabolism in patients with dilated cardiomyopathy

173

Coronary microvascular function and myocardial metabolism in the pig model of pacing induced progressive LV dysfunction

174

Coronary Microvascular Reactivity After Ischemic Cold Storage and Reperfusion

175

Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results From the National Heart, Lung and Blood Institute WISE (Womenʹs Ischemia Syndrome Evaluation) Study

176

Coronary microvascular response to intracoronary administration of nicorandil

177

Coronary microvascular spasm and angina pectoris

178

Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina

179

Coronary microvascular spasm in patients with vasospastic angina

180

Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor

181

Coronary morphologic findings after stent implantation

182

Coronary MRI: More Pretty Pictures or Present-Day Value?

183

Coronary Multidetector Computed Tomography: A New Standard for Preoperative Risk Assessment?

184

Coronary Myocardial Bridges: Pathophysiology and Clinical Relevance

185

Coronary narrowing secondary to compression by pericardial hydatid cyst

186

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use

187

Coronary No-reflow Phenomenon: A Review of Therapeutic Pharmacological Agents

188

Coronary obstruction by a calcific pericardial ring

189

Coronary operations in octogenarians: can we select the patients?

190

Coronary operations in patients with spinal cord injury

191

Coronary ostial enlargement to prevent stenosis after prosthetic aortic valve replacement

192

Coronary ostial patch angioplasty in children

193

Coronary ostial reconstruction

194

Coronary Ostial Stenosis After Aortic Valve Replacement, Revisited

195

Coronary perforation during unprotected left main angioplasty. Management with conservative approach: a case report

196

Coronary perforation managed with covered stent

197

Coronary perfusate composition influences diastolic properties, myocardial water content, and histologic characteristics of the rat left ventricle

198

Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial

199

Coronary perfusion pressure during cardiopulmonary resuscitation

200

Coronary plague instability in severe acute respiratory syndrome

201

Coronary plaque as a replacement for age as a risk factor in global risk assessment

202

Coronary Plaque Burden and Cardiovascular Risk Factors: Single-Point Versus Serial Assessment

203

Coronary plaque burden detected by multislice computed tomography after acute myocardial infarction with near-normal coronary arteries by angiography

204

Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation

205

Coronary plaque composition, macrophage infiltration and tissue factor content in patients with diabetes mellitus

206

Coronary Plaque Composition: Multifactorial Contribution

207

Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease

208

Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography,

209

Coronary plaque regression: role of low density lipoprotein-apheresis

210

Coronary Plaque Rupture and Vessel Remodeling

211

Coronary pseudoaneurysm: An uncommon cause of P.U.O. after a common procedure: An interesting case report

212

Coronary Pseudoaneurysm: An Unreported Complication of Castleman’s Disease

213

Coronary pseudoaneurysms are a known complication of the Bentall wrap-inclusion method of composite valve grafting. We describe two cases to illustrate a straightforward technique for repair and prevention of coronary pseudoaneurysm formation.

214

Coronary pseudo-lesions induced in the left anterior descending and right coronary artery by the angioplasty guide-wire

215

Coronary reactivity to nitroglycerin: Intravascular ultrasound evidence for the importance of plaque distribution

216

Coronary Recanalization by Elective Angioplasty Prevents Ventricular Dilation After Anterior Myocardial Infarction

217

Coronary recanalization in anterior myocardial infarction: The open perforator hypothesis

218

Coronary Reimplantation After Neoaortic Reconstruction Can Yield Better Result in Arterial Switch Operation: Comparison With Open Trap Door Technique

219

Coronary Reimplantatıon After Neoaortic Reconstruction in Arterial Switch Operation

220

Coronary Reimplantation During Jatene Procedure

221

Coronary reimplantation in aortic root replacement: a method to avoid tension

222

Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study

223

Coronary reoperation via small laparotomy using right gastroepiploic artery without CPB

224

Coronary reoperations: recurrence of angina and clinical outcome with and without cardiopulmonary bypass

225

Coronary reperfusion: numerators searching for denominators

226

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

227

Coronary restenosis: a new strategy for the future?

228

Coronary restenosis: a review of mechanisms and management

229

Coronary Revascularization and Cardiac Catheterization in the United States: Trends in Racial Differences

230

Coronary revascularization and quality of life

231

Coronary Revascularization Before Noncardiac Vascular Surgery: One More Step Forward in Understanding Its Role

232

Coronary Revascularization for Patients With Diabetes: Updated Data Favor Coronary Artery Bypass Grafting

233

Coronary revascularization in older women and men in the United States: trends in ethnic differences

234

Coronary Revascularization in the Community: A Population-Based Study, 1990 to 2004 Original Research Article

235

Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction

236

Coronary revascularization is under-utilized in medicaid patients with acute myocardial infarction

237

Coronary revascularization of the circumflex

238

Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease: Has the Final Chapter Been Written?

239

Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])

240

Coronary Revascularization Surgery After Myocardial Infarction: Impact of Bypass Surgery on Survival After Thrombolysis

241

Coronary revascularization with arterial conduits collateral to the lower limb

242

Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency

243

Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future

244

Coronary revascularization without cardiopulmonary bypass in patients with pectus excavatum

245

Coronary Revascularization Without Cardiopulmonary Bypass Versus the Conventional Approach in High-Risk Patients

246

Coronary risk assessment in women

247

Coronary risk assessment in women

248

Coronary risk assessment methods and cholesterol lowering

249

Coronary risk assessment methods and cholesterol lowering

250

Coronary risk assessment methods and cholesterol lowering

251

Coronary risk assessment methods and cholesterol lowering

252

Coronary risk assessment methods and cholesterol lowering

253

Coronary risk assessment methods and cholesterol lowering

254

Coronary risk assessment methods and cholesterol lowering

255

Coronary risk factor status after percutaneous transluminal coronary angioplasty

256

Coronary risk factors and coronary atheroma burden at severely narrowing segments

257

Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants

258

Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) Original Research Article

259

Coronary risk factors in Indians

260

Coronary risk factors in patients with early-onset coronary disease and normal coronariography

261

Coronary risk factors in people from the Indian subcontinent

262

Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India

263

Coronary risk factors in women six months after coronary artery bypass grafting

264

Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study

265

Coronary risk reduction through intensive community-based lifestyle intervention: the Coronary Health Improvement Project (CHIP) experience

266

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis: The Heinz Nixdorf Recall Study

267

Coronary rotational ablation for calcific coronary artery stenosis in a young child

268

Coronary ruptured plaque mimicking spontaneous coronary dissection in a young woman

269

Coronary Segmental Responses to Acetylcholine and Bradykinin in Patients With Atherosclerotic Risk Factors

270

Coronary sinus adrenomedullin rises in response to myocardial injury

271

Coronary Sinus and Ascending Aortic Levels of Aldosterone, Angiotensin II, and B-Type Natriuretic Peptide in Patients With Aortic Stenosis and in Patients With Coronary Heart Disease

272

Coronary sinus catheterization via a femoral vein

273

Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure

274

Coronary sinus diverticulum as a cause of resistant posteroseptal pathway ablation

275

Coronary sinus interventions in cardiac surgery, 2nd edition: Edited by Werner Mohl, MD, PhD, Georgetown, Texas, Landes Bioscience, 2000, 224 pp, illustrated, $99.00, ISBN: 1-58706-006-X

276

Coronary Sinus Orifice Atresia With Left Superior Vena Cava in Patients With Univentricular Heart

277

Coronary sinus ostial atresia with persistent left superior vena cava

278

Coronary sinus ostial atresia: A rare associated anomaly that should be remembered in patients undergoing univentricular palliation

279

Coronary sinus pacing mistaken as interventricular septal perforation and subsequent left ventricular pacing by a transvenously introduced pacing electrode

280

Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open-Label, Multicenter, Safety Feasibility First-in-Man Study Original Research Article

281

Coronary Sinus Stenting for the Management of Left Ventricular Lead Displacement during Resynchronization Therapy: A Report of Two Cases

282

Coronary sinus thrombosis after cannulation during cardiopulmonary bypass

283

Coronary Slow Flow Phenomenon Clinical Findings and Predictors

284

Coronary slow flow: Benign or ominous?

285

Coronary Slow-Flow Phenomenon or Syndrome Y: A Microvascular Angina Awaiting Recognition

286

Coronary spasm after injection of ondansetron: Case report and review of the literature

287

Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome?

288

Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management Original Research Article

289

Coronary stenosis dilatation induced by L-arginine

290

291

Coronary stent assessment on multidetector computed tomography: Source and predictors of image distortion

292

Coronary Stent Design and New Clinical Trial Insights

293

Coronary Stent Fracture and In-Stent Restenosis at Coronary Computed Tomography

294

Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

295

Coronary stent fracture in a saphenous vein graft to right coronary artery — Successful treatment by the novel use of the Jomed coronary stent graft: Case report and review of the literature

296

Coronary stent grafts covered by a polytetrafluoroethylene membrane

297

Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution

298

Coronary stent implantation in acute myocardial infarction,

299

Coronary stent implantation in patients older than 75 years of age: Clinical profile and initial and long-term (3 years) outcome

300

Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial

301

Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes

302

Coronary stent occlusion following strenuous exertion: is the risk actual? Is it preventable?

303

Coronary stent occlusion: Thrombus horribilis

304

Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy

305

Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

306

Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial

307

Coronary stenting after rotational atherectomy in diffuse lesions of the small coronary artery: comparison with balloon angioplasty prior to stenting

308

Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: Results in a series of consecutive patients

309

Coronary Stenting and Inflammation

310

Coronary Stenting and Inflammation: Implications for Further Surgical and Medical Treatment

311

Coronary stenting and use of abciximab

312

Coronary stenting during acute myocardial infarction. Results from the stent without coumadin French registry

313

Coronary stenting for transplant coronary artery disease

314

Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts

315

Coronary stenting in cardiac allograft vasculopathy

316

Coronary stenting in diabetic patients: Results from the ROSETTA registry

317

Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction

318

Coronary stenting in the setting of spontaneous coronary artery dissection

319

Coronary stenting of bifurcation lesions using “T” or “reverse Y” configuration with Wiktor stent

320

Coronary stenting of unprotected left main stem stenoses in elderly patients unsuitable for coronary surgery

321

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting

322

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting: Reply

323

Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials

324

Coronary stenting versus balloon angioplasty in small vessels

325

Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies Original Research Article

326

Coronary stenting with novel stainless steel balloon-expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model

327

Coronary stenting with angioscopic guidance

328

Coronary stenting with AVE microstents in acute myocardial infarction

329

Coronary stents: A health system perspective, ,

330

Coronary stents: A materials perspective

331

Coronary stents: An industry perspective, ,

332

Coronary stents—open choices for closed arteries

333

Coronary subclavian steal: A recurrent case with notes on detecting the threat potential

334

Coronary Superficial and Spotty Calcium Deposits in Culprit Coronary Lesions of Acute Coronary Syndrome as Determined by Optical Coherence Tomography

335

Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass

336

Coronary Surgery in Patients With Preexisting Chronic Atrial Fibrillation: Early and Midterm Clinical Outcome

337

Coronary surgery with intermittent aortic cross-clamping: a word of caution on the incidence of cerebrovascular accidents: letter 2

338

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response

339

Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis Original Research Article

340

Coronary thrombosis

341

Coronary thrombosis associated with inherited protein S deficiency: A case report

342

Coronary Thrombosis From Large, Nonprotruding, Superficial Calcified Coronary Plaques

343

Coronary Thrombosis without Dissection following Blunt Trauma

344

Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect

345

Coronary to pulmonary artery fistula detected by transthoracic echocardiography

346

Coronary tracheal collaterals after heart–lung transplant

347

Coronary vascular dysfunction in premenopausal women with diabetes mellitus

348

Coronary Vascular Morphology in Pressure-overload Left Ventricular Hypertrophy

349

Coronary vascular reactivity is abnormal in patients with Chagasʹ heart disease

350

Coronary Vascular Remodeling in Association With Endothelial Dysfunction

351

Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries

352

Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs

353

Coronary Vascular Responsiveness to Adenosine Is Impaired Additively by Blockade of Nitric Oxide Synthesis and Sulfonylure

354

Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism

355

Coronary vasoconstriction induced by mental stress (simulated public speaking)

356

Coronary Vasoconstrictive Effects of Neuropeptide Y and Their Modulation by the ATP-Sensitive Potassium Channel in Anesthetized Dogs

357

Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study

358

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction

359

Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction

360

Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats

361

Coronary vasodilatory capacity and flow reserve are attenuated in normal myocardium supplied by bypass grafts

362

Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery

363

Coronary vasomotility and myocardial blood flow early after heart transplantation

364

Coronary Vasomotion After Percutaneous Transluminal Coronary Angioplasty Depends on the Severity of the Culprit Lesion

365

Coronary vasomotion and exercise‑induced adaptations in coronary artery disease patients: A systematic review and meta‑analysis

366

Coronary vasomotion during dynamic exercise: Influence of intravenous and intracoronary nicardipine

367

Coronary vasomotor function in a normotensive, nondiabetic referral population with normal coronary arteriograms

368

Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain

369

Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration

370

Coronary Vasospasm and Coronary Atherosclerosis: Do We Have to Choose?

371

Coronary vasospasm and raspberry ketones weight-loss supplement: Is there a connection?

372

Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil

373

Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease

374

Coronary vasospasm due to hypercholinergic crisis: An example of normal coronary arteriogram and myocardial infarction

375

Coronary vasospasm during an adenosine stress test

376

Coronary vasospasm in a patient suffering from sarin poisoning

377

Coronary Vasospasm Induced During Isoproterenol Head-Up Tilt Test

378

Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis

379

Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease

380

Coronary vein balloon angioplasty forleft ventricular pacemaker lead implantation

381

Coronary venous angioplasty to a ring- like stricture preventing left ventricular lead insertion

382

Coronary venous imaging with electron beam computed tomographic angiography: Three-dimensional mapping and relationship with coronary arteries

383

Coronary ventricular fistula as a complication of PTCA: A case report and literature review

384

Coronary vessel trees from 3D imagery: A topological approach

385

Coronary wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations

386

Coronary-artery bypass surgery and the brain: persisting concerns

387

Coronary-Artery Stent

388

Coronary-Cameral Fistula Connecting the Left Anterior Descending Artery and the First Obtuse Marginal Artery to the Left Ventricle: A Rare Finding

389

Coronary-cameral fistula in an asymptomatic adult patient

390

Coronary-coronary bypass using the radial artery

391

Coronary-coronary radial artery graft for single, distal LAD lesion

392

Coronary-pulmonary artery fistula: Heart-on-a-heart appearance

393

Coronary-pulmonary fistula serving as a collateral source to the occluded coronary artery in a patient with myocardial infarction

394

Coronary-pulmonary steal syndrome

395

Coronary-Subclavian Steal Syndrome Following CABG: a Case Report and Literature Review

396

Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis “Case Report”

397

Coronary–Subclavian Steal Syndrome: An usual cause of refractory unstable angina

398

Coronary-to-coronary bypass using a free internal mammary artery: An alternative

399

Coronas and iridescence in mountain wave clouds

400

Coronas of balleans

401

CORONAS-F observations of active phenomena on the sun Original Research Article

402

CORONAS-F satellite: Tasks for study of particle acceleration Original Research Article

403

Coronatine alleviates salinity stress in cotton by improving the antioxidative defense system and radical-scavenging activity

404

Coronatine, a more powerful elicitor for inducing taxane biosynthesis in Taxus media cell cultures than methyl jasmonate

405

Coronavirus (COVID-19) and Possibilities for Criminal Law Reaction in Europe: A Review

406

Coronavirus (COVID-19) Infection in Newborns

407

Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach

408

Coronavirus and Divine Justice and its Relation to the Issue of Natural and Moral Evil

409

Coronavirus and Emergence of an Extraordinary Political Economy: editorial note

410

Coronavirus Anxiety: The Predictive Role of Perfectionism and Self-compassion

411

Coronavirus as a possible cause of severe acute respiratory syndrome

412

Coronavirus confirmed as cause of SARS

413

Coronavirus COVID-19 and its Effect on Erection and Patients’ Sexual Disorders: A Narrative Review

414

Coronavirus Disease (COVID-19) and Dental Treatment

415

Coronavirus Disease (COVID-19): 10 Questions and Discussion Points for Diabetes and COVID-19

416

Coronavirus Disease 19 with Spontaneous Pneumomediastinum: A Report of Three Cases

417

Coronavirus disease 2019 (COVID-19) and cardiovascular events

418

Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology

419

Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics

420

Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts

421

Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series

422

Coronavirus Disease 2019 (COVID-19) Outbreak in Pediatrics and the Role of Pediatricians: A Systematic Review

423

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission

424

Coronavirus Disease 2019 (COVID-19): review study

425

Coronavirus Disease 2019- Challenges Today and Tomorrow in Orthodontic Practice: A Review

426

Coronavirus Disease 2019 in Children with Acute Respiratory Infection: A Study From Southeastern Iran

427

Coronavirus Disease 2019 in Patients with Thalassemia; Emerging Challenges

428

Coronavirus Disease 2019 Occupational Considerations for Surgeons: A Review Article

429

Coronavirus Disease 2019 Vaccine Hesitancy in the Kurdistan Region: A Cross-Sectional National Survey

430

Coronavirus disease 2019: Global Contamination and Global Cleanup

431

Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential

432

Coronavirus Disease in Cardiovascular Patients: Clinical Characteristics and Final Prognosis

433

Coronavirus Disease-19 (COVID-19) Presenting with Severe Acute Pancreatitis: A Case Report from Iran

434

Coronavirus Disease-2019 Infection in Neonates of an Infected Pregnant Mother with Triplets

435

Coronavirus in severe acute respiratory syndrome (SARS)

436

Coronavirus Incidence Rate Estimation from Social Media Data in Iran

437

Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features

438

Coronavirus N Protein N-Terminal Domain (NTD) Specifically Binds the Transcriptional Regulatory Sequence (TRS) and Melts TRS-cTRS RNA Duplexes

439

Coronavirus Pandemic and Worries during Pregnancy; a Letter to Editor

440

Coronavirus phylogeny based on triplets of nucleic acids bases

441

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses

442

Coronavirus, Its Neurologic Manifestations, and Complications

443

Coronavirus: Bibliometric analysis of scientific publications from 1968 to 2020

444

Coronavirus: Discover the Structure of Global Knowledge, Hidden Patterns & Emerging Events

445

Coronavirus: Nursing Students’ Knowledge and Risk Perception of Clinical Practice during the Pandemic

446

Coronavirus: Where Has All the Health Economics Gone?

447

Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2

448

Coronaviruses Pathogens in Human in Third Millennium (SARS-CoV, MERS, COVID-19): A Review Article

449

Coronavirus-induced Anxiety among Pregnant Women

450

Coronavirus-nephropathy; renal involvement in COVID-19

451

Coronavirus-Related Opportunities for Promoting Occupational Health and Safety

452

Coroner autopsies originating from complaints to the police in a Nigerian Urban centre

453

Coroner Wakley: two remarkable eyewitness accounts

454

Coroners and public health

455

Coronilla juncea is both a nutritive fodder shrub and useful in the rehabilitation of abandoned Mediterranean marginal farmland

456

Coronin 1B Antagonizes Cortactin and Remodels Arp2/3-Containing Actin Branches in Lamellipodia

457

Coronin 1B Coordinates Arp2/3 Complex and Cofilin Activities at the Leading Edge

458

Coronin-1A Stabilizes F-Actin by Bridging Adjacent Actin Protomers and Stapling Opposite Strands of the Actin Filament

459

Coronoid systems with perfect matchings Original Research Article

460

Corono-radicular biological restoration of maxillary central incisors by direct method

461

Corosolic acid induces apoptosis through mitochondrial pathway and caspases activation in human cervix adenocarcinoma HeLa cells

462

Corosolic acid induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro

463

COROT: A minisat for pionnier science, asteroseismology and planets finding Original Research Article

464

CoRoT: Harvest of the exoplanet program

465

Co-rotation constructions of residuated semigroups

466

Corotation resonances and planetary formation

467

Co-rotational beam elements with warping effects in instability problems Original Research Article

468

Co-rotational dynamic analysis of flexible beams Original Research Article

469

Co-rotational finite element formulation for thin-walled beams with generic open section Original Research Article

470

Co-rotational flat facet triangular elements for shell instability analyses Original Research Article

471

Co-rotational formulation for geometric nonlinear analysis of doubly symmetric thin-walled beams Original Research Article

472

Corotational formulation for nonlinear dynamics of beams with arbitrary thin-walled open cross-sections

473

Corotational mixed finite element formulation for thin-walled beams with generic cross-section

474

Corotational non-linear analysis of thin plates and shells using a new shell element

475

Corotational nonlinear dynamic analysis of laminated composite shells

476

CORPORA AMYLACEA IN HUMAN CADAVERIC BRAIN AGE RELATED DIFFERENCES

477

CORPORA IN LANGUAGE RESEARCH IN MALAYSIA

478

Corpora Lutea Diameter, Plasma Progesterone Concentration and Follicular Development in PGF2α and CIDR Estrus Synchronized Goats

479

CORPORA USE IN THE TEACHING OF ENGLISH WRITING

480

Corporal punishment and child adjustment

481

Corporal Punishment and its Effects in Pakistan

482

Corporal punishment and physical maltreatment against children: A community study on Chinese parents in Hong Kong

483

Corporal punishment and primary prevention of physical abuse

484

Corporate "central nervous system" software

485

Corporate and Institutional Transparency for Economic Growth in Europe, Oxelheim Lars (Ed.). Elsevier, Amsterdam (2006) 444p, € 76.99, ISBN 0-08-044665-5.

486

Corporate and social performance links in the gaming industry

487

Corporate asset purchases and sales: Theory and evidence

488

Corporate bankruptcies and official bail-outs: A cost–benefit analysis

489

Corporate behavior and competitiveness: impact of environmental regulation on Chinese firms

490

CORPORATE BLOGS AS ACORPORATECOMMUNICATION STRATEGY

491

Corporate board attributes and bankruptcy

492

Corporate boards and regulation: The effect of the Sarbanes–Oxley Act and the exchange listing requirements on firm value

493

Corporate body name changes: Helping the user search efficiently and effectively

494

Corporate bond default risk: A 150-year perspective

495

Corporate bond liquidity and matrix pricing

496

Corporate bond liquidity before and after the onset of the subprime crisis

497

Corporate bond ratings changes and economic instability: Evidence from the Korean financial crisis

498

Corporate Call Policy for Nonconvertible Bonds

499

Corporate capital structure and the characteristics of suppliers and customers

500

Corporate capital structure in turbulent times: a case study of the US airline industry

501

Corporate capture and Coca-Cola

502

Corporate cash flow and stock price exposures to foreign exchange rate risk

503

Corporate cash holdings and CEO compensation incentives

504

Corporate cash holdings: An empirical investigation of UK companies

505

Corporate Champions: doing good more effectively

506

Corporate characteristics, governance attributes and the extent of voluntary disclosure in Bangladesh

507

Corporate citizenship and public relations: The importance and interactivity of social responsibility issues on corporate websites

508

Corporate citizenship and the employee/citizen solider

509

Corporate comets or typical trajectories?: Corporate dynamics in the 1990s

510

Corporate communications managers in large firms: new challenges

511

Corporate Community Involvement. The Definitive Guide to Maximizing Your Business’ Societal Engagement

512

Corporate contracting for health care

513

Corporate control and enterprise structure in the Canadian economy: 1972–1987

514

Corporate control and industry structure in global communications: an introduction

515

Corporate control and real investment in incomplete markets

516

Corporate control and the market for managerial labour: On the decision to go public

517

Corporate control, bank risk taking, and the health of the banking industry

518

Corporate control, expected underpricing, and the choice of issuance mechanism in unseasoned equity markets

519

Corporate cost of occupational accidents: an activity-based analysis

520

Corporate Credibility’s Role in Consumers’ Attitudes and Purchase Intentions When a High versus a Low Credibility Endorser Is Used in the Ad

521

Corporate credit risk modeling and the macroeconomy

522

CORPORATE CRIME ANNOUNCEMENT EFFECTS ON STOCK PERFORMANCE: AN EMPIRICAL STUDY IN MALAYSIA

523

corporate crime in indonesian criminal law system

524

Corporate Cultural Dimensions, Social Responsibility and Financial Performance

525

Corporate Culture and Commitment: Impact on Performance of International New Product Development Programs

526

Corporate culture and the bottom line

527

Corporate culture, absorptive capacity and IT success

528

Corporate culture, related chief executive officer traits, and the development of executive information systems

529

Corporate debt and output pricing in developing countries: Industry-level evidence from Turkey

530

Corporate Default Prediction among Tehran Stock Exchange’s Selected Industries

531

Corporate derivatives use and firm value: Evidence from Turkey

532

Corporate disclosure quality, earnings smoothing, and earningsʹ timeliness

533

Corporate disclosures made by Chinese listed companies

534

Corporate distress and lobbying: Evidence from the Stimulus Act

535

Corporate diversification and asymmetric information: evidence from stock market trading characteristics

536

Corporate diversification and efficiency of manufacturing firms listed in Bursa Malaysia

537

Corporate diversification and performance: evidence on production efficiency

538

Corporate diversification and shareholder value: a survey of recent literature

539

Corporate diversification strategies and capital structure

540

Corporate diversification, information asymmetry and firm performance: Evidence from Tehran Stock Exchange

541

Corporate Diversification, Value Maximization, and Organizational Capabilities

542

Corporate diversification: identifying new businesses systematically in the diversified firm

543

Corporate diversification’s effects on Efficiency and productivity: case study of Manufacturing firms listed in Bursa Malaysia

544

Corporate dynamic transparency: the new ICT-driven ethics?

545

Corporate earnings and the equity premium

546

Corporate elites as informants in qualitative international business research

547

Corporate enterprise: a new reality for hospitality organisations?

548

Corporate entrepreneurs and privatized firms in russia, ukraine, and belarus

549

Corporate entrepreneurship and financial performance: The case of management leveraged buyouts

550

Corporate entrepreneurship antecedents and performance in agricultural advisory services corporations in west of Iran

551

Corporate entrepreneurship in network organizations:: How subsidiary initiative drives internal market efficiency

552

Corporate Entrepreneurship in Training Institutions

553

Corporate entrepreneurship:: antidote or oxymoron?

554

Corporate environme ntal behavior research: informing environme ntal policy

555

Corporate environmental and resource management: In search of a new managerial paradigm

556

Corporate environmental disclosure, financial markets and the media: An international perspective

557

Corporate environmental disclosures: are they useful in determining environmental performance?

558

Corporate environmental disclosures: Competitive disclosure hypothesis using 1991 annual report data

559

Corporate Environmental Innovation (CEI): a government initiative to support corporate sustainability leadership

560

Corporate Environmental Management 2: Culture and Organisations : , Earthscan Publications Ltd (1997) 192 £15.95. Building to Last: The Challenge for Business Leaders, , Earthscan Publications Ltd (1997) 204 £15.95

561

Corporate environmental management and regulation of mining operations in the Cyclades, Greece

562

Corporate environmental market responsiveness: A model of individual and organizational drivers

563

Corporate environmental responsibility in the supply chain

564

Corporate environmental responsiveness in India: lessons from a developing country

565

Corporate environmental strategy: The avalanche of change since Bhopal : B.W. Piasecki (author) John Wiley & Sons, 1995, 180 pp, ISBN 0-471-10627-5, US$24.95

566

Corporate environmentalism: the construct and its measurement

567

CORPORATE EQUAL OPPORTUNITIES (NON-) DISCLOSURE

568

Corporate ergonomics programme at automobiles Peugeot-Sochaux

569

Corporate ergonomics programme at BCM Airdrie

570

Corporate ergonomics programme at Ford Motor Company

571

Corporate ergonomics programme at Scottish & Newcastle

572

Corporate ergonomics programme at Volvo Car Corporation

573

Corporate Excellence in the Year 2000 : L K T , Century (1996), 350 pp., £18.99

574

Corporate Farm Performance in Russia, 1991–1995: An Efficiency Analysis

575

Corporate finance and state enterprise reform in China

576

Corporate finance—Theory and practice

577

Corporate Financial Accounting and Reporting: by Tim Sutton, Financial Times/Prentice Hall, Harlow, Essex, England, 2000, xiii+754 pp

578

Corporate financial decision-makers’ perceptions of workplace safety

579

Corporate financial disclosure in emerging markets: Does economic development matter?

580

CORPORATE FINANCIAL MANAGEMENT: TIME TO CHANGE THE “COST OF CAPITAL” PARADIGM?

581

Corporate Financial Reporting. Theory and Practice: Andrew Higson (Ed.); Sage, 2003, 228 pages, ISBN 0-7619-7141-6 (£24.99)

582

Corporate Financial Reporting: A Global Perspective: by Hervé Stolowy and Michel J. Lebas, Thomson, London, UK, 2002, xxvi+636 pp. ISBN: 1-861-52753-5, £31.99

583

Corporate Financial Reporting: By Bhabatosh Banerjee and Arun Kumar Basu (Eds.), University of Calcutta, Calcutta, 2001, vi+275 pages

584

Corporate Financial Strategies for Global Competitiveness

585

Corporate Financing and Goverance in Japan: The Road to the Future: by Takeo Hoshi and Anil Kashyap, MIT Press, 2002.

586

Corporate financing decisions when investors take the path of least resistance

587

Corporate financing decisions, managerial market timing, and real investment

588

Corporate firms in the 21st century: A note.

589

Corporate focus and stock returns,

590

Corporate focus and value creation evidence from spinoffs

591

Corporate focus versus diversification: the role of growth opportunities and cashflow

592

Corporate fraud, systematic risk, and shareholder enrichment

593

Corporate futures: social responsibility in the tourism industry: Angela Kalisch; Tourism Concern, London, 2002, 47pp, price £15 (£10 for members), ISBN 0-9528567-7-8

594

Corporate goodness and shareholder wealth

595

CORPORATE GOVERNANCE AND ACCOUNTING MODELS OF THE REPORTING ENTITY,

596

Corporate governance and accounting systems: a critical perspective

597

Corporate Governance and Audit Fees: Evidence from a Developing Country

598

Corporate Governance and Audit Opinion Shopping: Evidence from Iran

599

Corporate governance and audit report lag in Malaysia

600

Corporate governance and bank performance: A joint analysis of the static, selection, and dynamic effects of domestic, foreign, and state ownership

601

Corporate governance and board effectiveness

602

Corporate Governance and Corporate Social Responsibility: The Case of Small, Medium, and Large Firms

603

Corporate Governance and Credit Risk in the Iranian Banking Industry

604

Corporate governance and dividend pay-out policy in Germany

605

Corporate governance and dividend policy in emerging markets

606

Corporate governance and dividend policy: A comparison of Chinese firms listed in Hong Kong and in the Mainland

607

Corporate governance and earnings management in the Chinese listed companies: A tunneling perspective

608

Corporate Governance and Employee Ownership in an Economic Crisis: Enterprise Strategies in the Former USSR

609

Corporate governance and executive compensation

610

Corporate governance and firm cash holdings in the US

611

Corporate governance and firm performance: Evidence from Japanese manufacturing industries after the lost decade

612

Corporate governance and firm profitability: evidence from Korea before the economic crisis

613

Corporate governance and firm valuation

614

Corporate governance and firm value: evidence from the Korean financial crisis

615

Corporate governance and firm value\In Japan: Evidence from 1985 to 199

616

Corporate governance and globalization. Long range planning issues: Stephen S. Cohen & Gavin Boyd (Eds); Edward Elgar Publishing, Cheltenham, UK, 2000, pp. 373

617

Corporate governance and information asymmetry

618

Corporate governance and innovation: The UK compared with the US and ‘insider’ economies

619

CORPORATE GOVERNANCE AND INSTITUTIONAL INVESTORS: EVIDENCE FROM MALAYSIA

620

Corporate governance and intellectual capital

621

Corporate Governance and Investment Decisions in Deposit Money Banks in Nigeria

622

Corporate governance and investment in Central and Eastern Europe

623

Corporate governance and investment in East Asian firms—empirical analysis of family-controlled firms

624

Corporate Governance and Iranian Banking Economic Value Added

625

Corporate Governance and Liquidity Creation: Evidence from Iranian Banks

626

Corporate Governance and Liquidity Management: Evidence from Nigerian Deposit Money Banks

627

Corporate governance and lobbying strategies

628

Corporate governance and manager turnover: An unusual social experiment

629

Corporate governance and market valuation in China

630

Corporate governance and market valuation of capital and R&D investments

631

Corporate governance and mass privatisation: A theoretical investigation of transformations in legal and economic relationships

632

Corporate governance and merger performance: Learning from the Australian experience

633

Corporate governance and ownership structure of target companies and the outcome of takeovers

634

Corporate governance and pay-for-performance: The impact of earnings management

635

Corporate governance and performance of small high-tech firms in Sweden

636

Corporate governance and profit manipulation: a French field study

637

CORPORATE GOVERNANCE an‎d PUBLIC RELATIONS: A QUALITATIVE RESEARCH WITH PUBLIC RELATIONS EXPERTS

638

Corporate Governance and R D Reporting in Malaysian MESDAQ Market

639

Corporate governance and recent consolidation in the banking industry

640

CORPORATE GOVERNANCE AND ROLE OF CEO IN ENGINEERING COMPANIES

641

Corporate governance and shareholder initiatives: Empirical evidence

642

Corporate governance and shareholder patience

643

Corporate governance and state-owned shares in China listed companies

644

Corporate governance and the quality of financial analysts’ information

645

Corporate governance and the spinoff decision

646

Corporate governance and the value of cash holdings

647

Corporate governance and voluntary disclosure

648

Corporate Governance and Voluntary Disclosure Practices: Evidence from a Two Tier Board Systems in Indonesia

649

Corporate governance assessment in company board structure

650

Corporate governance attributes, firm characteristics and the level of corporate disclosure: Evidence from the Indian listed firms

651

Corporate Governance Characteristics and Company Performance

652

Corporate Governance Characteristics and Discretionary Accruals Among Non-Financial Firms Listed in Nairobi Securities Exchange

653

Corporate governance digest

654

Corporate governance effectiveness during institutional transitio

655

Corporate governance in China: An overview

656

Corporate governance in china: Explosive growth and new patterns of ownership

657

Corporate Governance in Insurance Sector and The Impact of Corporate Governance Committee

658

Corporate Governance in Russia:: towards a European, US, or Russian Model?

659

Corporate governance in South Korea: the chaebol experience

660

Corporate governance in the Asian countries

661

Corporate governance in the Asian financial crisis

662

CORPORATE GOVERNANCE IN THE CONTEXT OF CORPORATE SUSTAINABILITY: THE BIRTH, THE DEVELOPMENT an‎d THE EVALUATION OF THE CONCEPT

663

Corporate governance in the deregulated telecommunications industry: lessons from the airline industry

664

Corporate Governance in the Former Soviet Union

665

Corporate Governance in the Former Soviet Union: An Overview

666

Corporate Governance In Turkey: An Overview

667

Corporate governance indices and firmsʹ market values: Time series evidence from Russia

668

Corporate governance issues and director compensation structure in Spanish companies

669

Corporate Governance Mechanisms and Financial Performance: Evidence from the Listed Bank in Bangladesh

670

Corporate governance of Japanese banks

671

Corporate governance over the business cycle

672

Corporate Governance Perspectives for Zimbabwean SMEs

673

Corporate governance post-Enron: Effective reforms, or closing the stable door?

674

Corporate Governance Practices and Environmental Reporting of Companies in Malaysia: Finding Possibilities of Double Thumbs Up

675

Corporate Governance Practices in Bangladesh: A Comparative Analysis between Conventional Banks and Islamic Banks

676

Corporate governance practices, CEO characteristics and firm performance

677

Corporate governance proposals and shareholder activism: the role of institutional investors

678

Corporate governance provisions and firm ownership: Firm-level evidence from Eastern Europe

679

Corporate Governance Quality :A Literature Review

680

Corporate Governance Structure, Legal Environment, and Valuation

681

Corporate governance when founders are directors

682

Corporate Governance with the Institutional Theory Approach on Regional Development Banks in Indonesia

683

Corporate Governance, Accountability, and Pressures to Perform: An International Study: by Istemi S. Demirag, JAI Press, Stamford, CT, 1998, xv+395 pp.

684

Corporate governance, bank specific characteristics, banking industry characteristics, and Intellectual Capital (IC) performance of banks in Arab Gulf Cooperation Council (GCC) countries

685

Corporate governance, chief executive officer compensation, and firm performance

686

Corporate governance, competition policy and industrial policy

687

Corporate governance, corporate social responsibility and corporate risk: Evidence on Indonesia

688

Corporate governance, dividend payout policy, and the interrelation between dividends, R&D, and capital investment

689

Corporate Governance, Executive Directors and Level of Voluntary Disclosure: The Case of Public Listed Companies in Thailand

690

Corporate governance, investor protection, and performance in emerging markets

691

Corporate governance, ownership dispersion and efficiency: Empirical evidence from Austrian cooperative banking

692

Corporate governance, Sarbanes-Oxley, and small-cap firm performance

693

Corporate governance, shareholder rights and firm diversification: An empirical analysis

694

Corporate governance, strategic philanthropy, and public policy

695

Corporate governance, top executive compensation and firm performance\In Japan

696

Corporate governance, tourism growth and firm performance: Evidence from publicly listed tourism firms in five Middle Eastern countries

697

Corporate governance: Accountability, enterprise and international comparisons, 2005

698

Corporate Governance: Board Structure, Information Technology and CSR Reporting

699

CORPORATE GOVERNANCE: CAN CREDITORS FIT IN WITH COMPANIES’ BOARD OF DIRECTORS?

700

Corporate governance: Kenneth A. Kim, John R. Nofsinger; Pearson Education Inc., 94 pages, ISBN 0131423878, £19.99

701

CORPORATE GOVERNANCE: NOMINEE DIRECTOR THE GATEKEEPER

702

CORPORATE GOVERNANCE: OVERVIEW AND RESEARCH AGENDA

703

Corporate Governance: SMEs Experience in Metro Cebu, Philippines

704

Corporate Governance: Theory and Some Insights into the Malaysian Practices

705

Corporate governance\In New Zealand: The effect of the 1993 Companies Act on the relation between board composition and firm performance

706

Corporate government digest

707

Corporate groups, dual-class shares and the value of voting rights

708

Corporate Harm Minimisation: Promises and Perils; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019”

709

Corporate heritage identity management and the multi-modal implementation of a corporate heritage identity

710

Corporate identity: The role of mission statements

711

Corporate image and corporate reputation in customers’ retention decisions in services

712

Corporate image of zakat institutions in Malaysia

713

Corporate imagesʹ impact on consumersʹ product choices: The case of multinational foreign subsidiaries

714

Corporate Inertia and Information Asymmetry: Evidence from Iran

715

Corporate Information Protection Program: Concept of Operations

716

Corporate initiatives in ergonomics—an introduction

717

Corporate Insurance and Managerial Incentives

718

Corporate integration and market liberalisation in the EU

719

Corporate Integrity and Information Asymmetry: Evidence from Iran.

720

Corporate intelligence dissemination as a consequence of intranet effectiveness: an empirical study

721

Corporate international activities and cash holdings

722

Corporate Internet Reporting in Emerging Economic Countries: The Malaysian Perspective

723

Corporate investment and financing under asymmetric information

724

Corporate investment myopia: a horserace of the theories

725

Corporate investment, financing, and dividend policies in the high-tech industry

726

Corporate Killing For Malaysia: A Preliminary Consideration

727

Corporate knowledge transfer via interlocking directorates: a network analysis approach

728

Corporate Leadership: Reflections of a CEO and CEO Advisor

729

Corporate learning: A knowledge management perspective

730

Corporate leverage and currency crises

731

Corporate life cycle and share repurchases: Evidence from the Taiwan Stock Market

732

Corporate lobbying in the UK: an analysis of attitudes towards the ASBʹs 1995 deferred taxation proposals

733

CORPORATE MAKAHIKI: THE GOVERNING TELOS OF PEACE

734

Corporate management of the Northwestern Hawaiian Islands lobster fishery

735

Corporate mandatory disclosure practices in Bangladesh

736

Corporate Membership in CIRP

737

Corporate Membership in CIRP

738

Corporate Membership in CIRP

739

Corporate Membership in CIRP

740

Corporate memories as a tool for knowledge management

741

Corporate mergers and acquisitions: One more wave to consider

742

Corporate mergers and the problems of IS integration

743

Corporate mindset of innovating firms: Influences on new product performance

744

Corporate misreporting and bank loan contracting

745

Corporate motivation and performance in R&D alliances

746

Corporate ontologies and concurrent engineering

747

Corporate optimal production planning with varying environmental costs: A grey compromise programming approach

748

Corporate Ownership and Governance in Russi

749

Corporate ownership and the value of a vote in an emerging market

750

Corporate ownership structure and bank loan syndicate structure

751

Corporate ownership structure and the choice between bank debt and public debt

752

Corporate partial acquisitions, total firm valuation and the effect of financing method

753

Corporate payout policy and managerial stock incentives

754

Corporate Performance and Board Structure in Belgian Companies

755

Corporate performance and CEO compensation in China

756

Corporate performance implications of extended stakeholder management: New insights on mediation and moderation effects

757

Corporate Performance, CEO Power and CEO Turnover: Evidence from Malaysian Public Listed Companies

758

Corporate philanthropic practices

759

Corporate philanthropy, attitude towards corporations, and purchase intentions: A South Korea study

760

Corporate policies restricting trading by insiders

761

Corporate Political Activity: A Literature Review and Research Agenda

762

Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy

763

Corporate portal: a tool for knowledge management synchronization

764

Corporate portals: a literature review of a new concept in Information Management

765

Corporate Portfolio Analysis Tools Revisited: Assessing Causes that May Explain Their Scholarly Disdain

766

Corporate Power Strategies: Getting the Upper Hand with Interest Groups, Media and Government: Otto Lerbinger; Newton, MA, Barrington Press, 2001, 336 pp., $35

767

Corporate precautionary cash holdings

768

Corporate profit tax, capital mobility, and formula apportionment

769

Corporate Qualification of the Mentor in the Dual Education System

770

Corporate Real Estate in Malaysia Higher Learning Environment

771

Corporate Rehabilitation: Informal Corporate Rescue Mechanisms for Troubled Companies in the United Kingdom and Malaysia

772

Corporate Relations in the Hellenistic Polis

773

Corporate Religion: Jesper Kunde, Financial Times, Prentice Hall (2000), 278 pp. plus index, £24.99

774

Corporate report obfuscation: artefact or phenomenon?

775

CORPORATE REPORTING ON HUMAN RIGHTS: CONSTRUCTION COMPANIES IN MALAYSIA

776

Corporate reporting on the Internet by German companies

777

Corporate Reputation and Competitiveness: by Gary Davies, with Rosa Chun, Rui Vinhas da Silva and Stuart Roper, Routledge (2002) 272 pp., £24.99

778

Corporate reputation and the stock market

779

Corporate Reputation in Businesses, Managing and Measuring Corporate Reputation: A Research

780

CORPORATE REPUTATION OF NON-PROFIT ORGANISATIONS: KIZILAY CASE

781

Corporate Resilience and Performance in Food Industry SMEs During COVID-19

782

Corporate responses to political costs: an examination of the relation between environmental disclosure and earnings management

783

Corporate responsibility and the triple bottom line

784

Corporate responsibility and the war on terrorism

785

Corporate Responsibility for Environmental Human Rights Violation: A Case Study of Indonesia

786

Corporate responsibility for socio-economic transformation: A focus on broad-based black economic empowerment and its implementation in South Africa

787

Corporate responsibility for sustainable development: a review and conceptual comparison of market- and stakeholder-oriented strategies

788

Corporate Responsibility for Wealth Creation and Human Rights: a Book Project

789

Corporate responsibility in the UK tourism industry

790

Corporate responsibility reporting by large pulp and paper companies

791

Corporate Responsibility via Malaysian Contract Law: A Concern for Consumer Protection

792

Corporate restructuring : , Harvard Business School Press (1994), 227 pp., £25.95

793

Corporate Restructuring and Its Wealth Effects: The Case of Lion Group

794

Corporate restructuring and performance: An agency perspective on the complete buyout cycle

795

Corporate restructuring during performance declines in Japan

796

Corporate restructuring in a collusive oligopoly

797

Corporate restructuring in Japan: an event-study analysis

798

Corporate Restructuring of British and German Non-financial Firms in the Late 1990s

799

Corporate restructuring: A symptom of poor governance or a solution to past managerial mistakes?

800

Corporate Restructuring: Firm Characteristics and Performance

801

Corporate risk management and asymmetric information

802

Corporate risk management to reduce borrowing costs

803

Corporate Risk Strategy:: Does it Vary Across Business Activities?

804

Corporate risk-taking and performance: A 20 year look at the petroleum industry

805

Corporate rumor activity, belief and accuracy

806

Corporate silence: environmental disclosure and the north american free trade agreement

807

Corporate social and environmental disclosure in developing countries: Evidence from Iran

808

Corporate social and environmental responsibility in web-based reports: Currency in the banking sector?

809

Corporate social audits—this time around

810

Corporate social disclosures by listed companies on their web sites: an international comparison

811

Corporate Social Performance and Internal Control

812

Corporate social performance, financial performance and market value behavior: An information asymmetry perspective

813

Corporate social reporting and reputation risk management

814

Corporate social reporting and stakeholder accountability: The missing link

815

CORPORATE SOCIAL REPORTING PRACTICES IN WESTERN EUROPE: LEGITIMATING CORPORATE BEHAVIOUR?,

816

Corporate Social Responsibilities (CSR) Themes from Bangladesh Perspective

817

Corporate social responsibilities and stock returns: Stochastic dominance approach

818

Corporate social responsibilities, consumer trust and corporate reputation: South Korean consumersʹ perspectives

819

Corporate Social responsibilities, their concepts and standards

820

Corporate Social Responsibility

821

Corporate social responsibility (CSR)

822

Corporate Social Responsibility (CSR) Employee Outcomes in the Aviation Industry during the COVID-19 Pandemic Era. A Conceptual Framework

823

Corporate Social Responsibility (CSR) initiatives in elevating community capacity building: The case of chilli farming in Bukit Awang, Pasir Puteh, Kelantan

824

Corporate social responsibility and CEO risk incentives from the behavioral agency model perspective Implications for idiosyncratic risk

825

Corporate Social Responsibility and community development: Perspective of the recepients

826

Corporate social responsibility and consumersʹ attributions and brand evaluations in a product–harm crisis

827

Corporate social responsibility and environme ntal research and developme nt

828

Corporate social responsibility and firm performance in the airline industry: The moderating role of oil prices

829

Corporate social responsibility and food risk management in China; a management perspective

830

Corporate Social Responsibility and Investor’s Intention to Invest: Analyzing the Role of Corporate Identity and Corporate Image

831

Corporate Social Responsibility and Labor-Managed Duopoly with Wage Rise as Strategic Commitment

832

Corporate Social Responsibility and Poor’s Child Well Being in Developing Customer’s Loyalty

833

Corporate Social Responsibility and Reaction Functions of Labor-Managed Firms with Lifetime Employment as Strategic Commitment

834

Corporate social responsibility and stakeholder value maximization: Evidence from mergers

835

Corporate Social Responsibility and Stock Price Crash Risk: Evidence from an Emerging Market

836

Corporate social responsibility and the case of Summitville mine

837

Corporate social responsibility and tourism: Hotel companies in Phuket, Thailand, after the Indian Ocean tsunami

838

Corporate social responsibility and universities: A study of top 10 world universitiesʹ websites

839

Corporate Social Responsibility and Value at Risk: Petrochemical Companies listed on Tehran Stock Exchange

840

CORPORATE SOCIAL RESPONSIBILITY COMMUNICATION OF LEADING TURKISH CORPORATIONS: AN OBSERVATION OF WEB SITES

841

Corporate social responsibility disclosure in Kenya: The Nairobi stock exchange

842

Corporate Social Responsibility Disclosure: A Tawhidic Approach

843

Corporate Social Responsibility Disclosures and Board Structure: Evidence from Malaysia

844

CORPORATE SOCIAL RESPONSIBILITY EFFECT ON CONSUMER PATRONAGE-MANAGEMENT PERSPECTIVE: CASE STUDY OF A TELECOMMUNICATION COMPANY IN NIGERIA

845

Corporate social responsibility for implementation of sustainable energy development in Baltic States

846

Corporate social responsibility in fortune magazineʹs top 50 companies: State of action and salient trends

847

Corporate Social Responsibility in Global Supply Chains: A Procedural Justice Perspective

848

Corporate Social Responsibility in Iranian Agricultural Sector Governmental Public Policy Making necessities in AgriBusiness Partnerships

849

Corporate Social Responsibility in the Coffee Sector:: The Dynamics of MNC Responses and Code Development

850

Corporate social responsibility in the mining industry: Exploring trends in social and environmental disclosure

851

Corporate social responsibility in the relationship between accounting conservatism and investment efficiency

852

Corporate Social Responsibility in the Wake of the Asian Tsunami:: A Comparative Case Study of Two Sri Lankan Companies

853

Corporate social responsibility in times of financial crisis

854

CORPORATE SOCIAL RESPONSIBILITY OF MAJOR COMPANIES IN INDIA

855

Corporate Social Responsibility of Northwestern University

856

Corporate Social Responsibility Partnership to Alleviate Poverty in Kulon Progo Regency

857

Corporate social responsibility practice in resolving conflict of interests in a sustainable supply chain

858

Corporate social responsibility strategies, dynamic capability and organizational performance: Cases of top Taiwan-selected benchmark enterprises

859

Corporate Social Responsibility- Sustainability Nexus: A Systematic Literature Review and Bibliometric Analysis

860

Corporate Social Responsibility to Employees: Considering Common Law Vis-à-vis Islamic Law Principles

861

Corporate Social Responsibility, Challenges, Prospects and Its Impact on Infrastructural Developments in West African Economies

862

Corporate social responsibility, mining and “audit culture”

863

Corporate Social Responsibility: A Stakeholder and Process Approach

864

Corporate social responsibility: Doing well by doing good

865

Corporate social responsibility: The disclosure–performance gap

866

Corporate Social Responsibility: Trends and Development In Malaysia

867

Corporate Social Responsibility:: Moving Beyond Investment Towards Measuring Outcomes

868

Corporate Social Responsiveness:: Exploring the Dynamics of “Bad Episodes”

869

Corporate spinoffs and information asymmetry between investors

870

Corporate spin-offs as a value enhancing technique when faced with legal liability

871

Corporate spin-offs, bankruptcy, investment, and the value of debt

872

Corporate sponsorship questioned

873

Corporate strategic technological partnerships in the European information and communications technology industry

874

Corporate strategies for the Asia Pacific region

875

Corporate strategies, environmental forces, and performance measures: a weighting decision support system using the k-nearest neighbor technique

876

Corporate strategy

877

Corporate strategy and parenting theory

878

Corporate strategy and the environment: a portfolio approach

879

Corporate strategy for tourism : John Tribe International Thomson Business Press London (1997) 214 pp, 45 figures, 22 tables, bibliography, index, price ??? ISBN 0 415 14204 0

880

Corporate strategy in a small open economy: reducing product diversification while increasing international diversification

881

Corporate strategy in multibusiness firms

882

Corporate Structure and Equity Offerings: Are There Benefits to Diversification?

883

Corporate Structure Events Involving Regulated Utilities: The Need for a Multidisciplinary, Multijurisdictional Approach

884

Corporate sustainability disclosure practices of selected banks: A trend analysis approach

885

CORPORATE SUSTAINABILITY IN SPORTS and ERP SYSTEM (EXAMPLE OF FENERBAHÇE SPORTS CLUB)

886

Corporate sustainability ratings: an investigation into how corporations use the Dow Jones Sustainability Index

887

Corporate sustainability reporting and the relations with evaluation and management frameworks: the Portuguese case

888

Corporate sustainability reporting index and baseline data for the cruise industry

889

Corporate sustainability: an integrative definition and framework to evaluate corporate practice and guide academic research

890

Corporate takeovers, firm performance, and board composition

891

Corporate tax avoidance and high-powered incentives

892

Corporate tax avoidance and stock price crash risk: Firm-level analysis

893

Corporate tax competition, tariffs and multinational firms

894

Corporate tax competition, tariffs and multinational firms

895

Corporate tax effects on the quality and quantity of FDI

896

Corporate tax policy, foreign firm ownership and thin capitalization

897

Corporate tax systems, multinational enterprises, and economic integration

898

Corporate taxation, debt financing and foreign-plant ownership

899

Corporate taxation, incumbency advantage and entry

900

Corporate Taxes 2001–2002/Individual Taxes 2001–2002—Worldwide Summaries: Compiled by PricewaterhouseCoopers, John Wiley & Sons, Inc., New York City, 2001, 922/573 pp. (US$190 for the 2-volume set)

901

Corporate taxes and intra-firm trade

902

Corporate taxes, growth and welfare in a Schumpeterian econom

903

corporate taxpayer compliance: slippery slope framework and planned behavior theory approaches

904

Corporate technological competence and the evolution of technological diversification: Felicia M. Fai, Cheltenham. Edward Elgar publishing. 2003. 194pp.

905

Corporate technology out-licensing: Motives and scope

906

Corporate Training for Effective Performance: edited by Martin Mulder, Wim J. Nijhof, and Robert O. Brinkerhoff. Kluwer Academic, Boston 1995

907

Corporate transparency, cream-skimming and FDI

908

Corporate Universities and Corporation- University Partnerships in Thailand: Complementing Education in Learning, Leadership and Change

909

Corporate use of derivatives and excess value of diversification

910

Corporate use of interest rate swaps: Theory and evidence

911

Corporate valuation and the resolution of bank insolvency in East Asia

912

Corporate valuation around the world: The effects of governance, growth, and openness

913

Corporate valuation, capital structure and risk management: A stochastic DCF approach

914

Corporate venture capital and the returns to acquiring portfolio companies

915

Corporate venture capital as a means of radical innovation: Relational fit, social capital, and knowledge transfer

916

Corporate versus independent new ventures: Resource, strategy, and performance differences

917

Corporate voting: Evidence from charter amendment proposals

918

Corporate Wellness Programs: Implementation Challenges in the Modern American Workplace

919

Corporation Identity: Associations of Logo and Color

920

Corporation nation: How corporations are taking over our lives and what we can do about it : by Charles Derber. New York: St. Martinʹs Press, 1998. 374 pp

921

Corporation-bashing in documentary film: A case study of news media coverage organizational response

922

Corporations and Health: The Need to Combine Forces to Improve Population Health

923

Corporations Response to the Energy Saving and Pollution Abatement Policy

924

Corporations vs. communities: Evolution of wireless services in the US and the devolution of local control

925

Corporatisation and accounting change: The role of accounting and accountants in a Malaysian public utility

926

Corporatism and structural change in the British accountancy profession, 1930–1957

927

Corporatism as an impediment to ecological sustenance: the case of Finnish waste management

928

Corporatism packaged in pluralist ideology: the case of Slovenia

929

Corporatism, labor unions and the safety net

930

CORPORATIZATION AND THE REGULATION OF ACCOUNTING SERVICES,

931

Corporeal creations

932

Corporeal Experience: A Haptic Way of Knowing

933

934

Corporectomy with and without bone graft for multilevel cervical spondylosis and ossification of the posterior longitudinal ligament

935

Corporeographies of pregnancy: bikini babes

936

Corprological and haematological parameters of albino mice (Mus musculus) concurrently infected with Heligmosomoides bakeri and Trypanosoma brucei

937

Corprological and Haematological Profile of Polo Horses Stabled in North – Central Nigeria

938

Corps enveloppants des algèbres de type Witt

939

Corps et modèles—Essai sur lʹhistoire de lʹalgèbre réelle.By Hourya Sinaceur. Paris: Librairie Philosophique J. Vrin

940

Corps pythagoriciens, fermatiens et P-réduisants Original Research Article

941

Corpse medicine: mummies, cannibals, and vampires

942

Corpses and the spread of cholera

943

Corpses and the spread of cholera

944

Corpus callosal morphology in early onset adolescent depression

945

Corpus callosotomy

946

Corpus callosotomy in a patient of hemimegalencephaly and Lennox–Gastaut syndrome

947

Corpus callosum and optic chiasm in early blind adults

948

Corpus callosum atrophy and neuropsychological outcome following carbon monoxide poisoning

949

Corpus callosum changes following shunting for hydrocephalus: case report and review of the literature

950

Corpus callosum defect with dilated lateral ventricles and an occipital cyst in an Egyptian child with Diamond-Blackfan anemia

951

Corpus Callosum Functional Activities in Children with Cerebral Palsy

952

Corpus callosum lipoma and complex partial seizures

953

Corpus callosum morphology, as measured with MRI, in dyslexic men

954

Corpus callosum shape and size in male patients with schizophrenia

955

Corpus callosum size and shape in individuals with current and past depression

956

Corpus callosum size in children with developmental language disorder

957

Corpus callosum size is linked to dichotic deafness and hemisphericity, not sex or handedness

958

Corpus Coranicum Projesi: Kur’an’ı Geç Antik Döneme Ait Bir Metin Olarak Okumak

959

Corpus Design for Malay Corpus-based Speech Synthesis System

960

Corpus di italiano parlato: Vol. 1: Introduzione, Vol. 2: Corpora, CD-Rom: Emanuela Cresti, Accademia della Crusca, Firenze, 2000, 282 (Vol. 1) and 389 (Vol. 2) pages, EUR 51,65

961

CORPUS LINGUISTICS STUDIES: INTERGENERATIONAL SOLIDARITY SCALE DEVELOPMENT

962

Corpus Linguistics Tools for Loanwords and Borrowings Studies

963

Corpus luteum function following single and double ovulation during estrous cycle in Sanjabi ewes

964

Corpus luteum size and plasma progesterone concentration in cows

965

Corpus relevance through co-word analysis: An application to plant proteints

966

CORPUS RESEARCH IN MALAYSIA: A BIBLIOGRAPHIC ANALYSIS

967

Corpus-based Application for Translation of English Grammatical Collocations in Azeri

968

Corpus-based approaches and discourse analysis in relation to reduplication and repetition

969

Corpus-based Approaches to Translation Studies

970

Corpus-based cross-language information retrieval in retrieval of highly relevant documents

971

Corpus-based exploration of linking adverbials of result: Discovering what ELT writing coursebooks lack

972

corpus-based materials and learning non-congruent idioms by iranian efl learners: enhanced and unenhanced input

973

Corpus-Based Materials and Learning Non-Congruent Idioms by Iranian EFL Learners: Enhanced and Unenhanced Input

974

Corpus-Based Statistical Screening for Content-Bearing Terms

975

Corpus-Bassed Analysis for Multi-Token Unists in Persian

976

Corpuscular oxidative stress in desert sheep naturally deficient in copper

977

CorpWiki: A self-regulating wiki to promote corporate collective intelligence through expert peer matching

978

Corrasion of a remoulded cohesive bed by saltating littorinid shells

979

Correct and incorrect use of multilinear regression

980

Correct application of Fresnel’s equations for intensity analysis of angle-resolved photoemission data

981

Correct behavior identification system in a Tagged World

982

Correct body posture in nurses: an application ofmotivational interviewing

983

Correct energy conservation in geothermal wellbore simulation

984

Correct Folding of the β-Barrel of the Human Membrane Protein VDAC Requires a Lipid Bilayer

985

Correct Identification of Animal Host Species Is Important in the Diagnosis of Zoonotic Diseases

986

Correct identification of limiting water data for water network synthesis

987

Correct initial boundary value problems for dispersive equations

988

Correct interpretation of heme protein spectra allows distinguishing between the heme and the protein dynamics

989

Correct models of fuzzy IF–THEN rules are continuous

990

Correct Optimization of Drug-Eluting Stents Should Be Regarded in the Same Light as POETry

991

Correct or combine? Mechanically integrating judgmental forecasts with statistical methods

992

Correct or incorrect application of CAPM? Correct or incorrect decisions with CAPM?

993

Correct sampling and measurement—the foundation of accurate metallurgical accounting

994

Correct testing of mark independence for marked point patterns

995

Correct testing of mark independence for marked point patterns

996

Correct transformation: From object-based graph grammars to PROMELA

997

Correct use of the Langmuir–Hinshelwood equation for proving the absence of a synergy effect in the photocatalytic degradation of phenol on a suspended mixture of titania and activated carbon Original Research Article

998

Correct Utilization of Exercise Electrocardiographic Leads in Differentiation of Men With Coronary Artery Disease from Patients With a Low Likelihood of Coronary Artery Disease Using Peak Exercise ST-Segment Depression

999

Correctable and Non-Correctable Viual Impairment in a Population-Baed ample of 12-Year-Old Autralian Children Original Reearch Article

1000

Correctable viual impairment in an older population: the blue mountain eye tudy

بازگشت